Tagged: james segermark

Listed on Manhattan Street Capital, InSitu Biologics Tops $2 Million Crowdfunding Under Reg A+

InSitu Biologics is reporting that it has topped $2 million using the Reg A+ crowdfunding exemption. The company anticipates reaching $10 million in equity capital as the campaign continues into 2019. InSitu Biologics is a biotech firm that claims positive initial results in pre-clinical studies… Read More

Send this to a friend